New research has uncovered distinct patterns of multimorbidity among patients with severe asthma across Europe, enhancing our understanding of how these comorbidities affect disease severity and treatment strategies. Severe asthma, often characterized by persistent symptoms and frequent exacerbations despite high-intensity therapy, is complicated by various coexisting conditions that can influence management approaches.
A comprehensive analysis conducted across 11 European countries, involving 2,690 patients, revealed that the presence of multiple additional health issues in severe asthma is not random. Instead, researchers identified three stable comorbidity clusters that are consistent across diverse regions, indicating possible underlying clinical phenotypes.
The first cluster links osteoporosis with weight gain induced by corticosteroids, emphasizing the long-term effects of steroid use. The second cluster associates eczema with allergic rhinitis, representing an allergic or atopic profile common in these patients. The third cluster connects chronic sinusitis with nasal polyps, underscoring a significant relationship with upper airway diseases.
In addition, other conditions such as obesity, bronchiectasis, gastro-oesophageal reflux disease, and various psychological factors demonstrated more ambiguous patterns, highlighting the heterogeneous nature of severe asthma presentations.
Patients were categorized into multimorbidity phenotypes based on the identified clusters. The most prevalent phenotype included sinonasal disease without a strong cluster association, while another substantial group exhibited no discernible pattern. Notably, the steroid-associated multimorbidity phenotype was linked to the most adverse clinical outcomes, manifesting in higher reliance on maintenance oral corticosteroids, diminished lung function, poorer asthma control, and increased exacerbation frequency.
A separate “maximal multimorbidity” phenotype exhibited a higher burden of comorbidities and an increased need for biologic therapies. These findings underscore the necessity for clinicians managing severe asthma to recognize these multimorbidity patterns rather than treating each condition in isolation. Early consideration of steroid-sparing strategies and closer monitoring for systemic complications may be vital for patients with steroid-linked multimorbidity.
The researchers advocate for a holistic approach to severe asthma, suggesting that attention to the clustering of comorbidities can facilitate personalized treatment strategies and enhance long-term patient outcomes.
This study represents a crucial advancement in the field, providing valuable insights into the complexities of severe asthma management. By identifying distinct multimorbidity phenotypes, healthcare providers can tailor treatment plans more effectively to improve patient care.
For more detailed insights, refer to the study conducted by Freeman A et al., published in the Lancet Regional Health Europe, which sheds light on multimorbidity phenotypes and associated characteristics in severe asthma.
Tags: Severe Asthma, Comorbidities, Multimorbidity, Health Research, Patient Care
Original Source: https://respiratory-therapy.com/disorders-diseases/chronic-pulmonary-disorders/asthma/comorbidity-clusters-for-severe-asthma/
Category :
Tags:
Publish Date: 2026-04-16 20:56:00
